OUTBREAK, EPIDEMIOLOGY, THERAPEUTICS AND PREVENTION OF CORONAVIRUS DISEASE-2019: A REVIEW

Zulfkar Latief Qadrie,M Khalid Ahmed Khan,Shahid Ud Din Wani,Surya Prakash Gautam

doi:10.22159/ijcpr.2020v12i5.39755

Zulfkar Latief Qadrie, M Khalid Ahmed Khan + Show 2 more

Open Access

https://doi.org/10.22159/ijcpr.2020v12i5.39755

Copy DOI

Abstract

The outbreak of pneumonia of unknown cause during December 2019 was reported from Wuhan City, Hubei province capital in China as its epicenter. Symptoms of pneumonia in several patients admitted to hospitals from Wuhan, China during December 2019. The sudden increase in the patients having the same symptoms, in due course the contributing means was isolated from the infected populace. In the present short report, we have summarized various public health measures, viz., early marking of the suspected patient, diagnosis, and supervision of the suspected cases that will help prevent Coronavirus disease in 2019. At the start, it was named as the 2019 novel coronavirus (2019-nCoV), and later it has been named Coronavirus disease 2019 (COVID-19) recently. Within a few weeks of a short period, the virus affected the other of China after Wuhan and later in two to three months, it is present in more than 140 countries around the globe and adding. As of 03rd August 2020, there have been 17.6 million established cases worldwide, and 680, 894 deaths have been documented, with 11,460,074 recovered. Worldwide, multiple trails are going on with the hope to find the treatment and some have positive results. On the other hand, because no vaccine is offered, the precautionary methods are the best way to fight the virus.

Highlights

Outbreaks of pneumonia of unknown cause during December, 2019 were reported from Wuhan City, Hubei province capital in Republic of China was the epicenter
Traditional immuno modulant drug, Chloroquine which is used in the treatment of malaria, reduces viral replication in other infections, as well as the Severe Acute Respiratory Syndrome (SARS-associated coronavirus (CoV)) and Middle East Respiratory Syndrome (MERS-CoV) recommended by In vitro studies [5,6,7]
Samples for the COVID-19 are taken from the upper respiratory tract meant for the test

Summary

Introduction

Outbreaks of pneumonia of unknown cause during December, 2019 were reported from Wuhan City, Hubei province capital in Republic of China was the epicenter. Traditional immuno modulant drug, Chloroquine which is used in the treatment of malaria, reduces viral replication in other infections, as well as the Severe Acute Respiratory Syndrome (SARS-associated coronavirus (CoV)) and Middle East Respiratory Syndrome (MERS-CoV) recommended by In vitro studies [5,6,7]. Four out of 9 infants presented with fever, 1 patient without any signs and symptoms, tested positive for COVID-19.

Results

Conclusion